VM3: Regulatory exchange and new/future approaches

VM3

The coordination group for mutual recognition and decentralised procedures veterinary medicinal products (CMDv), represented by its vice chair Beate Gasser, provided an update on the summary of product characteristics (SPC) harmonisation exercise and G.I.18 variations required to align with the quality review of documents (QRD) product information template v.9. Noting that the SPC harmonisation has now started for the first five products (Catosal, Finadyne, Estrumate, Domesedan and Planate), marketing authorisation holders (MAH) were invited to register interest for the 2024 process before 31 May.

 This is member-only content

To read this article, SIGN IN NOW if you are a TOPRA member.

 

Not a TOPRA member yet? Join our global community.

Five great reasons to become a TOPRA member:

  1. Great savings on our events and training.
  2. Be part of our dynamic international community.
  3. Contribute to the profession.
  4. Grow your skills and knowledge.
  5. Take your career to the next level.

Have you heard what you’re missing? Listen now to the RegRapPod podcast show, for free!